Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva M Compérat

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
European Urology|May 4, 2020
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 GuidelinesJ Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al.
European Urology|July 5, 2016
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder CancerJ Alfred Witjes, Thierry Lebret, Eva M Compérat, et al.
European Urology Oncology|July 2, 2020
European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 UpdateGeorgios Gakis, Harman M Bruins, Richard Cathomas, et al.
European Urology|July 19, 2022
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular TumoursHolger Moch, Mahul B Amin, Daniel M Berney, et al.
European Urology|August 14, 2022
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract TumorsGeorge J Netto, Mahul B Amin, Daniel M Berney, et al.
European Urology|October 6, 2022
Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization ClassificationGeorge J Netto, Mahul B Amin, Eva M Compérat, et al.
European Urology Oncology|December 24, 2019
The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline PanelHarman M Bruins, Erik Veskimäe, Virginia Hernández, et al.
European Urology|August 2, 2016
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines PanelThomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al.
European Urology|August 25, 2019
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 UpdateMarko Babjuk, Maximilian Burger, Eva M Compérat, et al.
European Urology|September 13, 2021
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)Marko Babjuk, Maximilian Burger, Otakar Capoun, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
European Urology|May 4, 2020
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 GuidelinesJ Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al.
European Urology|July 5, 2016
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder CancerJ Alfred Witjes, Thierry Lebret, Eva M Compérat, et al.
European Urology Oncology|July 2, 2020
European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 UpdateGeorgios Gakis, Harman M Bruins, Richard Cathomas, et al.
European Urology|July 19, 2022
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular TumoursHolger Moch, Mahul B Amin, Daniel M Berney, et al.
European Urology|August 14, 2022
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract TumorsGeorge J Netto, Mahul B Amin, Daniel M Berney, et al.
European Urology|October 6, 2022
Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization ClassificationGeorge J Netto, Mahul B Amin, Eva M Compérat, et al.
European Urology Oncology|December 24, 2019
The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline PanelHarman M Bruins, Erik Veskimäe, Virginia Hernández, et al.
European Urology|August 2, 2016
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines PanelThomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al.
European Urology|August 25, 2019
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 UpdateMarko Babjuk, Maximilian Burger, Eva M Compérat, et al.
European Urology|September 13, 2021
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)Marko Babjuk, Maximilian Burger, Otakar Capoun, et al.
Pageof 5